Unknown

Dataset Information

0

Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia

ABSTRACT:

SUBMITTER: Yao Y 

PROVIDER: S-EPMC10950817 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown NAP1L5 in acute myeloid leukemia: a prognostic biomarker and potential therapeutic target
| S-EPMC12331495 | biostudies-literature
Unknown Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.
| S-EPMC10134331 | biostudies-literature
Unknown SLC39A14 Is a Potential Therapy Target and Prognostic Biomarker for Acute Myeloid Leukemia
| S-EPMC12385646 | biostudies-literature
Unknown Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.
| S-EPMC7136967 | biostudies-literature
Unknown The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside.
| S-EPMC9503540 | biostudies-literature
Unknown CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia.
| S-EPMC7882723 | biostudies-literature
Unknown Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.
| S-EPMC5070622 | biostudies-literature
Unknown Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia.
| S-EPMC5016250 | biostudies-literature
Unknown SRSF7 serves as a potential therapeutic target in acute myeloid leukemia.
| S-EPMC12606998 | biostudies-literature
Unknown Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia.
| S-EPMC8114558 | biostudies-literature